Background Bioimpedance-based estimates of fluid overload have been widely studied and
systematically reviewed in populations of those undergoing dialysis, but data from …

Rationale & Objective Use of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-
proBNP) for cardiovascular (CV) risk assessment in patients with end-stage kidney disease …

Introduction: Fluid management in hemodialysis patients is a controversial topic. Brain
natriuretic peptide (BNP) is secreted from the heart in response to volume overload, and …

Background. The new polypeptide hormones adropin and irisin have a broad impact on
human metabolism and energy homeostasis. They could be potential biomarkers of cardiac …

Objective: This study was designed to explore the clinical significance of changes in
troponin T (cTnT), C-reactive protein (CRP) and amino-terminal pro-brain natriuretic peptide …

Background: Trimethylamine N-oxide (TMAO) has been identified as a new biomarker of
cardiovascular disease. Our aim was to evaluate the plasma levels of TMAO in patients with …

Natriuretic peptides, brain natriuretic peptide (BNP), and N‐terminal probrain natriuretic
peptide (NT‐proBNP) are mainly known as diagnostic markers for heart failure with high …

Although many alternative methods are present, maintaining ideal volume status in
peritoneal dialysis (PD) patients still rely on clinical evaluation due to lack of an evidence …

Purpose Exogenous ghrelin is associated with cardiovascular protection in experimental
and human studies. Nevertheless ESRD patients have increased ghrelin levels and severe …

Purpose To investigate a new noninvasive method to assess central venous pressure (CVP)
in hemodialysis patients, based on the ultrasonographic measurement of the collapsing …